Vision-Sciences, Inc.  

(Public, NASDAQ:VSCI)   Watch this stock  
Find more results for VSCI
1.05
-0.01 (-0.94%)
May 21 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.02 - 1.08
52 week 0.91 - 1.70
Open 1.08
Vol / Avg. 0.00/26,471.00
Mkt cap 48.53M
P/E     -
Div/yield     -
EPS -0.25
Shares 46.22M
Beta 1.22
Inst. own 6%
Jul 22, 2013
Q1 2014 Vision Sciences Inc Earnings Release Add to calendar
May 13, 2013
Q4 2013 Vision Sciences Inc Earnings Release
Apr 30, 2013
Q4 2013 Vision Sciences Inc Earnings Conference Call
Mar 19, 2013
Vision Sciences Inc at Canaccord Genuity Musculoskeletal Conference
Feb 27, 2013
Vision Sciences Inc at Lazard Medical Technology Snowbird Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '12) 2012
Net profit margin -39.90% -66.02%
Operating margin -38.61% -60.62%
EBITD margin - -55.63%
Return on average assets -53.98% -68.07%
Return on average equity - -362.67%
Employees 107 -
Carbon Disclosure Rating - -

Address

40 Ramland Road
ORANGEBURG, NY 10962
United States - Map
+1-845-3650600 (Phone)
+1-845-3650620 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Vision-Sciences, Inc. designs, develops, manufactures, and markets products for endoscopy, the science of using an instrument, known as an endoscope, to provide minimally invasive access to areas not readily visible to the human eye. The Company operates in two segments: medical and industrial. The medical segment designs, manufactures and sells its line of endoscopy-based products, including the flexible fiber and video endoscopes and its EndoSheath technology, for a variety of specialties and markets. The industrial segment, through the Company�s wholly owned subsidiary Machida Incorporated (Machida), designs, manufactures, and sells borescopes to a range of users, primarily in the aircraft engine manufacturing and aircraft engine maintenance industries.

Officers and directors

Lewis C. Pell Chairman of the Board
Age: 69
Bio & Compensation  - Reuters
Howard I. Zauberman Interim Chief Executive Officer
Age: 60
Bio & Compensation  - Reuters
Keith Darragh Principal Financial Officer, Principal Accounting Officer, Vice President - Finance
Bio & Compensation  - Reuters
Mark S. Landman Vice President - Disposables Operations
Age: 57
Bio & Compensation  - Reuters
Jitendra Patel Vice President - Industrial Division
Age: 58
Bio & Compensation  - Reuters
Warren Bielke Director - Strategic Initiatives, Director
Age: 65
Bio & Compensation  - Reuters
Cynthia F. Ansari Director
Bio & Compensation  - Reuters
David W. Anderson Independent Director
Age: 59
Bio & Compensation  - Reuters
Lothar Koob Independent Director
Age: 63
Bio & Compensation  - Reuters
Katsumi Oneda Independent Director
Age: 74
Bio & Compensation  - Reuters